isoproterenol has been researched along with Cardiomyopathy, Dilated in 90 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
Cardiomyopathy, Dilated: A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.
| Excerpt | Relevance | Reference |
|---|---|---|
| " miR-22-null hearts blunted cardiac hypertrophy and cardiac remodeling in response to 2 independent stressors: isoproterenol infusion and an activated calcineurin transgene." | 3.79 | MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. ( Chen, J; Hu, X; Huang, ZP; Kataoka, M; Seok, HY; Wang, DZ; Zhang, Z, 2013) |
| " Because adrenergic stimulation decreases serum K+ and Mg++, we decided to investigate the effects of a beta-receptor agonist, isoproterenol, on serum K+ and Mg++, and their consequences on the induction of tachycardia." | 3.68 | Effect of isoproterenol on serum potassium and magnesium. ( Beurrier, D; Brembilla-Perrot, B; le Van, D; Terrier de la Chaise, A, 1993) |
| "During a 3-year period we administered enoximone, a phosphodiesterase inhibitor with positive inotropic and vasodilator properties, to 73 pretransplantation patients with end-stage heart failure who exhibited a clinical requirement for additional inotropic support." | 3.68 | Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors. ( Gilbert, EM; Hershberger, RE; Lee, HR; Mealey, PC; Menlove, R; O'Connell, JB; Port, JD; Rasmussen, R; Renlund, DG; Volkman, K, 1991) |
| "IgG was prepared from patients with dilated cardiomyopathy, matched healthy donors (10 each) or commercial IgG preparations (2)." | 1.39 | Impact of human autoantibodies on β1-adrenergic receptor conformation, activity, and internalization. ( Boege, F; Bornholz, B; Christensen, MO; Felix, SB; Herda, LR; Hescheler, J; Lemoine, H; Mielke, C; Nguemo, F; Schäfer, C; Schmitmeier, S; Seidel, CA; Weidtkamp-Peters, S, 2013) |
| "Patients with dilated cardiomyopathy frequently develop autoantibodies against beta(1)-adrenoceptors, which can be removed by immunoadsorption." | 1.33 | Effects of immunoglobulin G from patients with dilated cardiomyopathy on rat cardiomyocytes. ( Adolph, E; Christ, T; Dobrev, D; Ravens, U; Schindelhauer, S; Wallukat, G; Wettwer, E, 2005) |
| "Rats treated with isoproterenol developed myocardial hypertrophy, and NDPK in the sarcolemma rose by 60% during 14 days of treatment." | 1.32 | Plasma membrane-associated nucleoside diphosphate kinase (nm23) in the heart is regulated by beta-adrenergic signaling. ( Hippe, HJ; Lutz, S; Mura, RA; Niroomand, F; Tiefenbacher, C, 2003) |
| "To test the hypothesis that dilated cardiomyopathy (DCM) is part of the pathological spectrum of HCM, we studied chamber morphology, exercise tolerance, hemodynamics, isolated heart function, adrenergic sensitivity, and embryonic gene expression in 8- to 11-mo-old male transgenic animals." | 1.31 | Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene. ( Colon-Rivera, C; Freeman, K; Grupp, IL; Iaccarino, G; Koch, WJ; Leinwand, LA; Moore, RL; Olsson, MC; Vikstrom, KL; Weinberger, HD, 2001) |
| "Isoproterenol was infused intravenously in 6 healthy individuals (control group) and 32 patients with dilated cardiomyopathy." | 1.31 | Impaired ability to secrete atrial natriuretic peptide in response to isoproterenol infusion in patients with dilated cardiomyopathy. ( Iida, K; Kawano, S; Masumi, T; Nishi, I; Yamaguchi, I, 2001) |
| "This child developed significant acute dilated cardiomyopathy and severe CNS depression 2 hours after ingesting 3200 mg of propranolol." | 1.30 | Acute dilated cardiomyopathy and central nervous system toxicity following propranolol intoxication. ( Lifshitz, M; Zalzstein, E; Zucker, N, 1999) |
| "Sixteen patients with dilated cardiomyopathy were studied to define the abnormality of the beta-adrenergic pathway non-invasively, using echocardiographic left ventricular responses to isoproterenol (ISP; 0." | 1.29 | The diversity of left ventricular responses to isoproterenol and dibutyryl cyclic AMP infusion in patients with dilated cardiomyopathy. ( Fujieda, K; Iida, K; Kawao, S; Sugishita, Y; Yamaguchi, I; Yukisada, K, 1995) |
| "In a few patients, hypertrophic cardiomyopathy has been reported to progress to a phase characterized by systolic dysfunction and left ventricular dilation, resembling dilated cardiomyopathy." | 1.29 | Response to isoproterenol as a prognostic indicator of evolution from hypertrophic cardiomyopathy to a phase resembling dilated cardiomyopathy. ( Fujieda, K; Iida, K; Iwasaki, Y; Kawano, S; Magdi, ES; Sugishita, Y; Tabei, F; Yamaguchi, I; Yukisada, K, 1995) |
| "For both control and dilated cardiomyopathy groups, 3,5,3'-triiodo-L-thyronine caused a significant increase in myocyte contractile function." | 1.29 | The novel effects of 3,5,3'-triiodo-L-thyronine on myocyte contractile function and beta-adrenergic responsiveness in dilated cardiomyopathy. ( Crawford, FA; Kato, S; Spinale, FG; Walker, JD, 1994) |
| "In this model of dilated cardiomyopathy: (1) relaxation is markedly prolonged; (2) the response to beta adrenergic stimulation is diminished; (3) Mg-ATPase activities and myofibrillar protein content are reduced; and (4) sympathetic activity in the heart is markedly increased with depletion of noradrenaline stores." | 1.29 | Pathophysiological and biochemical characterisation of an avian model of dilated cardiomyopathy: comparison to findings in human dilated cardiomyopathy. ( Fuleihan, F; Glass, MG; Gwathmey, JK; Hajjar, RJ; Liao, R; Young, JB, 1993) |
| "Dilated cardiomyopathy was induced by rapid atrial pacing (240 beats/min, 3 weeks) in 5 pigs." | 1.29 | Right and left ventricular geometry and myocyte contractile processes with dilated cardiomyopathy: myocyte growth and beta-adrenergic responsiveness. ( Crawford, FA; Gillette, PC; McMahon, WS; Mukherjee, R; Spinale, FG, 1996) |
| "Left ventricular hypertrophy was defined as an inter-ventricular thickness or posterior wall thickness > or = 13 mm." | 1.29 | Pathophysiologic significance of left ventricular hypertrophy in dilated cardiomyopathy. ( el Sersi, M; Fujieda, K; Iida, K; Iwasaki, Y; Kawano, S; Masumi, T; Sugishita, Y; Tabei, F; Yamaguchi, I, 1996) |
| "Sera from patients with dilated cardiomyopathy contain autoantibodies modifying cardiac beta-adrenergic pathways." | 1.28 | Assessment of immune modulation of beta-adrenergic pathways in human dilated cardiomyopathy: influence of methodologic factors. ( Goldenberg, IF; Limas, C; Limas, CJ, 1992) |
| "The degree of heart failure affected neither the potency (EC50: control: 0." | 1.28 | Different beta-adrenoceptor-effector coupling in human ventricular and atrial myocardium. ( Böhm, M; Erdmann, E; Pieske, B; Schwinger, RH, 1991) |
| "The electrical and contractile activity of isolated intracellularly stimulated ventricular myocytes has been recorded and dose-response curves to [Ca2+]o, and to beta adrenergic, alpha adrenergic, and muscarinic agonists and antagonists were examined." | 1.28 | Neurohumoral regulation of excitation-contraction coupling in ventricular myocytes from cardiomyopathic hamsters. ( Beresewicz, A; Horackova, M; Rowden, G; Wilkinson, M, 1991) |
| "Induction of congestive heart failure in a paced canine model resulted in alterations in the autonomic profile that resembled those seen in humans with ventricular failure." | 1.28 | Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. ( Binkley, PF; Cody, RJ; Haas, GJ; Nelson, SD; Nunziata, E, 1991) |
| "An arrhythmia was induced by isoprenaline in 17 of the 18 patients with confirmed right ventricular dysplasia (94%), 12 of whom had sustained mono or polymorphic ventricular tachycardia." | 1.28 | [Value of the isoprenaline test in arrhythmogenic heart diseases]. ( Barrat, JL; Haissaguerre, M; Le Métayer, P; Montserrat, P; Warin, JF, 1989) |
| "Chronic treatment of heart failure patients with beta-adrenoceptor antagonists leads to an up-regulation of cardiac beta-adrenoceptors, but in a subtype-selective fashion: beta 1-selective antagonists increase only cardiac beta 1-adrenoceptors, whereas non-selective antagonists increase both beta 1- and beta 2-adrenoceptors." | 1.28 | Drug- and disease-induced changes of human cardiac beta 1- and beta 2-adrenoceptors. ( Borst, HG; Brodde, OE; Maier, W; Michel, MC; Zerkowski, HR, 1989) |
| "Three patients had idiopathic dilated cardiomyopathy and one patient had inflammatory heart disease." | 1.27 | Increase in myocardial Gi-proteins in heart failure. ( Döring, V; Kalmar, P; Neumann, J; Schmitz, W; Scholz, H; von Meyerinck, L, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (13.33) | 18.7374 |
| 1990's | 33 (36.67) | 18.2507 |
| 2000's | 22 (24.44) | 29.6817 |
| 2010's | 23 (25.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Myers, VD | 2 |
| Tomar, D | 2 |
| Madesh, M | 2 |
| Wang, J | 4 |
| Song, J | 2 |
| Zhang, XQ | 2 |
| Gupta, MK | 1 |
| Tahrir, FG | 1 |
| Gordon, J | 2 |
| McClung, JM | 1 |
| Kontos, CD | 1 |
| Khalili, K | 2 |
| Cheung, JY | 2 |
| Feldman, AM | 3 |
| Schick, R | 1 |
| Mekies, LN | 1 |
| Shemer, Y | 1 |
| Eisen, B | 1 |
| Hallas, T | 1 |
| Ben Jehuda, R | 1 |
| Ben-Ari, M | 1 |
| Szantai, A | 1 |
| Willi, L | 1 |
| Shulman, R | 1 |
| Gramlich, M | 1 |
| Pane, LS | 1 |
| My, I | 1 |
| Freimark, D | 1 |
| Murgia, M | 1 |
| Santamaria, G | 1 |
| Gherghiceanu, M | 1 |
| Arad, M | 1 |
| Moretti, A | 1 |
| Binah, O | 1 |
| Lv, W | 1 |
| Qiao, L | 1 |
| Petrenko, N | 1 |
| Li, W | 1 |
| Owens, AT | 1 |
| McDermott-Roe, C | 1 |
| Musunuru, K | 1 |
| Nader, M | 1 |
| Alsolme, E | 1 |
| Alotaibi, S | 1 |
| Alsomali, R | 1 |
| Bakheet, D | 1 |
| Dzimiri, N | 1 |
| Huang, ZP | 1 |
| Chen, J | 1 |
| Seok, HY | 1 |
| Zhang, Z | 1 |
| Kataoka, M | 1 |
| Hu, X | 1 |
| Wang, DZ | 1 |
| Raymond, AR | 1 |
| Hodson, B | 1 |
| Woodiwiss, AJ | 3 |
| Norton, GR | 3 |
| Brooksbank, RL | 1 |
| Gonzalez-Valdes, I | 1 |
| Hidalgo, I | 1 |
| Bujarrabal, A | 1 |
| Lara-Pezzi, E | 1 |
| Padron-Barthe, L | 1 |
| Garcia-Pavia, P | 1 |
| Gómez-del Arco, P | 1 |
| Gomez, P | 1 |
| Redondo, JM | 1 |
| Ruiz-Cabello, JM | 1 |
| Jimenez-Borreguero, LJ | 1 |
| Enriquez, JA | 1 |
| de la Pompa, JL | 1 |
| Hidalgo, A | 1 |
| Gonzalez, S | 1 |
| Liu, GS | 1 |
| Morales, A | 1 |
| Vafiadaki, E | 1 |
| Lam, CK | 1 |
| Cai, WF | 1 |
| Haghighi, K | 2 |
| Adly, G | 1 |
| Hershberger, RE | 2 |
| Kranias, EG | 3 |
| Major, JL | 1 |
| Salih, M | 1 |
| Tuana, BS | 1 |
| Wu, H | 1 |
| Lee, J | 1 |
| Vincent, LG | 1 |
| Wang, Q | 1 |
| Gu, M | 1 |
| Lan, F | 1 |
| Churko, JM | 1 |
| Sallam, KI | 1 |
| Matsa, E | 1 |
| Sharma, A | 1 |
| Gold, JD | 1 |
| Engler, AJ | 1 |
| Xiang, YK | 1 |
| Bers, DM | 1 |
| Wu, JC | 1 |
| Hinson, JT | 1 |
| Chopra, A | 1 |
| Nafissi, N | 1 |
| Polacheck, WJ | 1 |
| Benson, CC | 1 |
| Swist, S | 1 |
| Gorham, J | 1 |
| Yang, L | 1 |
| Schafer, S | 1 |
| Sheng, CC | 1 |
| Haghighi, A | 1 |
| Homsy, J | 1 |
| Hubner, N | 1 |
| Church, G | 1 |
| Cook, SA | 1 |
| Linke, WA | 1 |
| Chen, CS | 1 |
| Seidman, JG | 1 |
| Seidman, CE | 1 |
| Tilley, DG | 1 |
| Gao, E | 1 |
| Hoffman, NE | 1 |
| Rabinowitz, J | 1 |
| Koch, WJ | 2 |
| Su, F | 1 |
| Li, L | 1 |
| Li, J | 1 |
| Drum, BM | 1 |
| Chen, Y | 1 |
| Yin, H | 1 |
| Guo, X | 1 |
| Luckey, SW | 1 |
| Gilbert, ML | 1 |
| McKnight, GS | 1 |
| Scott, JD | 1 |
| Santana, LF | 1 |
| Liu, Q | 1 |
| Klos, M | 1 |
| Mundada, L | 1 |
| Banerjee, I | 1 |
| Morgenstern, S | 1 |
| Myers, S | 1 |
| Leone, M | 1 |
| Kleid, M | 1 |
| Herron, T | 1 |
| Devaney, E | 1 |
| Nicolaou, P | 1 |
| Knöll, R | 1 |
| Fan, GC | 1 |
| Dorn, GW | 1 |
| Hasenfub, G | 1 |
| Fang, Q | 1 |
| Kan, H | 1 |
| Lewis, W | 1 |
| Chen, F | 1 |
| Sharma, P | 1 |
| Finkel, MS | 1 |
| Jilkina, O | 1 |
| Glogowski, M | 1 |
| Kuzio, B | 1 |
| Zhilkin, PA | 1 |
| Gussakovsky, E | 1 |
| Kupriyanov, VV | 1 |
| Muranaka, H | 1 |
| Marui, A | 1 |
| Tsukashita, M | 1 |
| Nakano, J | 1 |
| Ikeda, T | 1 |
| Sakata, R | 1 |
| Veliotes, DG | 1 |
| Correia, RJ | 1 |
| Strijdom, H | 1 |
| Badenhorst, D | 1 |
| Brooksbank, R | 1 |
| Haberland, A | 1 |
| Wallukat, G | 3 |
| Dahmen, C | 1 |
| Kage, A | 1 |
| Schimke, I | 1 |
| Pankonien, I | 1 |
| Alvarez, JL | 1 |
| Doller, A | 1 |
| Köhncke, C | 1 |
| Rotte, D | 1 |
| Regitz-Zagrosek, V | 1 |
| Morano, I | 1 |
| Haase, H | 1 |
| Booysen, HL | 1 |
| Opie, LH | 1 |
| Frantz, S | 1 |
| Klaiber, M | 1 |
| Baba, HA | 1 |
| Oberwinkler, H | 1 |
| Völker, K | 1 |
| Gaβner, B | 1 |
| Bayer, B | 1 |
| Abeβer, M | 1 |
| Schuh, K | 1 |
| Feil, R | 1 |
| Hofmann, F | 1 |
| Kuhn, M | 1 |
| Bornholz, B | 1 |
| Weidtkamp-Peters, S | 1 |
| Schmitmeier, S | 1 |
| Seidel, CA | 1 |
| Herda, LR | 1 |
| Felix, SB | 1 |
| Lemoine, H | 1 |
| Hescheler, J | 1 |
| Nguemo, F | 1 |
| Schäfer, C | 1 |
| Christensen, MO | 1 |
| Mielke, C | 1 |
| Boege, F | 1 |
| Du, Y | 1 |
| Yan, L | 1 |
| Zhan, W | 1 |
| Song, K | 1 |
| Han, X | 1 |
| Li, X | 1 |
| Cao, J | 1 |
| Liu, H | 1 |
| Biesiadecki, BJ | 1 |
| Elder, BD | 1 |
| Yu, ZB | 1 |
| Jin, JP | 1 |
| Mathier, MA | 2 |
| Shen, YT | 3 |
| Shannon, RP | 4 |
| Brixius, K | 1 |
| Wollmer, A | 1 |
| Bölck, B | 1 |
| Mehlhorn, U | 1 |
| Schwinger, RH | 5 |
| Lutz, S | 1 |
| Mura, RA | 1 |
| Hippe, HJ | 1 |
| Tiefenbacher, C | 1 |
| Niroomand, F | 1 |
| Del Corsso, C | 1 |
| de Carvalho, AC | 1 |
| Martino, HF | 1 |
| Varanda, WA | 1 |
| Lee, FY | 1 |
| Wei, J | 1 |
| Wang, JJ | 1 |
| Liu, HW | 1 |
| Shih, TC | 1 |
| Lin, CI | 1 |
| Brembilla-Perrot, B | 3 |
| Suty-Selton, C | 1 |
| Beurrier, D | 2 |
| Houriez, P | 1 |
| Nippert, M | 1 |
| Terrier de la Chaise, A | 2 |
| Louis, P | 1 |
| Claudon, O | 1 |
| Blangy, H | 1 |
| Juillière, Y | 2 |
| Nikolaidis, LA | 3 |
| Doverspike, A | 2 |
| Hentosz, T | 2 |
| Huerbin, R | 2 |
| Stolarski, CJ | 1 |
| Christ, T | 1 |
| Adolph, E | 1 |
| Schindelhauer, S | 1 |
| Wettwer, E | 1 |
| Dobrev, D | 1 |
| Ravens, U | 1 |
| Kawada, T | 1 |
| Masui, F | 1 |
| Tezuka, A | 1 |
| Ebisawa, T | 1 |
| Kumagai, H | 1 |
| Nakazawa, M | 1 |
| Toyo-Oka, T | 1 |
| Poornima, I | 1 |
| Parikh, P | 1 |
| Magovern, M | 1 |
| Tutor, AS | 1 |
| Penela, P | 1 |
| Mayor, F | 1 |
| Prystowsky, EN | 1 |
| Heger, JJ | 1 |
| Lloyd, EA | 1 |
| Zipes, DP | 1 |
| Fujieda, K | 3 |
| Iida, K | 6 |
| Kawao, S | 1 |
| Yukisada, K | 3 |
| Yamaguchi, I | 5 |
| Sugishita, Y | 4 |
| le Van, D | 1 |
| Eschenhagen, T | 2 |
| Diederich, M | 1 |
| Kluge, SH | 1 |
| Magnussen, O | 1 |
| Mene, U | 1 |
| Müller, F | 1 |
| Schmitz, W | 3 |
| Scholz, H | 3 |
| Weil, J | 1 |
| Sent, U | 1 |
| Kawano, S | 4 |
| Magdi, ES | 1 |
| Iwasaki, Y | 2 |
| Tabei, F | 2 |
| Walker, JD | 1 |
| Crawford, FA | 3 |
| Kato, S | 1 |
| Spinale, FG | 3 |
| Hajjar, RJ | 3 |
| Liao, R | 1 |
| Young, JB | 1 |
| Fuleihan, F | 1 |
| Glass, MG | 1 |
| Gwathmey, JK | 2 |
| Ungerer, M | 2 |
| Böhm, M | 8 |
| Elce, JS | 1 |
| Erdmann, E | 8 |
| Lohse, MJ | 1 |
| Koumi, S | 1 |
| Backer, CL | 1 |
| Arentzen, CE | 1 |
| Sato, R | 1 |
| McMahon, WS | 1 |
| Mukherjee, R | 1 |
| Gillette, PC | 1 |
| el Sersi, M | 1 |
| Masumi, T | 3 |
| Holubarsch, C | 2 |
| Lüdemann, J | 2 |
| Wiessner, S | 1 |
| Ruf, T | 2 |
| Schulte-Baukloh, H | 2 |
| Schmidt-Schweda, S | 1 |
| Pieske, B | 3 |
| Posival, H | 2 |
| Just, H | 2 |
| Podlowski, S | 1 |
| Luther, HP | 1 |
| Morwinski, R | 1 |
| Müller, J | 1 |
| Ettelbrück, S | 1 |
| Flesch, M | 1 |
| van Gilst, WH | 1 |
| Knorr, A | 1 |
| Maack, C | 1 |
| Pinto, YM | 1 |
| Paul, M | 1 |
| Teisman, AC | 1 |
| Zolk, O | 1 |
| Beyersdorf, F | 1 |
| Roth, DM | 1 |
| Gao, MH | 1 |
| Lai, NC | 1 |
| Drumm, J | 1 |
| Dalton, N | 1 |
| Zhou, JY | 1 |
| Zhu, J | 1 |
| Entrikin, D | 1 |
| Hammond, HK | 1 |
| Lifshitz, M | 1 |
| Zucker, N | 1 |
| Zalzstein, E | 1 |
| Ward, DM | 1 |
| Forrester, SD | 1 |
| DeFrancesco, TC | 1 |
| Troy, GC | 1 |
| Freeman, K | 1 |
| Colon-Rivera, C | 1 |
| Olsson, MC | 1 |
| Moore, RL | 1 |
| Weinberger, HD | 1 |
| Grupp, IL | 2 |
| Vikstrom, KL | 1 |
| Iaccarino, G | 1 |
| Leinwand, LA | 1 |
| Nishi, I | 2 |
| Moniotte, S | 1 |
| Kobzik, L | 1 |
| Feron, O | 1 |
| Trochu, JN | 1 |
| Gauthier, C | 1 |
| Balligand, JL | 1 |
| Stolarski, C | 1 |
| Washington, B | 1 |
| Butler, K | 1 |
| Doye, AA | 1 |
| Jang, M | 1 |
| Funakoshi, H | 1 |
| Kubota, T | 1 |
| Machida, Y | 1 |
| Kawamura, N | 1 |
| Tsutsui, H | 1 |
| Shimokawa, H | 1 |
| Takeshita, A | 1 |
| Carr, AN | 1 |
| Schmidt, AG | 1 |
| Suzuki, Y | 1 |
| del Monte, F | 1 |
| Sato, Y | 1 |
| Lanner, C | 1 |
| Breeden, K | 1 |
| Jing, SL | 1 |
| Allen, PB | 1 |
| Greengard, P | 1 |
| Yatani, A | 1 |
| Hoit, BD | 1 |
| DePaoli-Roach, AA | 1 |
| Bristow, MR | 1 |
| Minobe, W | 1 |
| Rasmussen, R | 2 |
| Larrabee, P | 1 |
| Skerl, L | 1 |
| Klein, JW | 1 |
| Anderson, FL | 1 |
| Murray, J | 1 |
| Mestroni, L | 1 |
| Karwande, SV | 1 |
| Limas, CJ | 2 |
| Goldenberg, IF | 1 |
| Limas, C | 2 |
| Burchell, SA | 1 |
| Tanaka, R | 1 |
| Zile, MR | 1 |
| Gierschik, P | 2 |
| Mende, U | 1 |
| Nose, M | 1 |
| Schulte am Esch, J | 1 |
| Sempell, R | 1 |
| Warnholtz, A | 1 |
| Wüstel, JM | 1 |
| La Rosée, K | 2 |
| Schmidt, U | 1 |
| Schulz, C | 1 |
| Lee, HR | 1 |
| Port, JD | 1 |
| Renlund, DG | 1 |
| O'Connell, JB | 1 |
| Gilbert, EM | 1 |
| Mealey, PC | 1 |
| Volkman, K | 1 |
| Menlove, R | 1 |
| Mittmann, C | 1 |
| Beuckelmann, DJ | 1 |
| Näbauer, M | 1 |
| Horackova, M | 1 |
| Beresewicz, A | 1 |
| Rowden, G | 1 |
| Wilkinson, M | 1 |
| Binkley, PF | 1 |
| Nunziata, E | 1 |
| Haas, GJ | 1 |
| Nelson, SD | 1 |
| Cody, RJ | 1 |
| Donetti, J | 1 |
| de la Chaise, AT | 1 |
| Sadoul, N | 1 |
| Aliot, E | 1 |
| Jakobs, KH | 1 |
| Schnabel, P | 1 |
| Haissaguerre, M | 1 |
| Montserrat, P | 1 |
| Le Métayer, P | 1 |
| Barrat, JL | 1 |
| Warin, JF | 1 |
| Denniss, AR | 1 |
| Marsh, JD | 1 |
| Quigg, RJ | 1 |
| Gordon, JB | 1 |
| Colucci, WS | 1 |
| Brodde, OE | 1 |
| Zerkowski, HR | 1 |
| Borst, HG | 1 |
| Maier, W | 1 |
| Michel, MC | 1 |
| Romão, N | 1 |
| Weaver, GE | 1 |
| Feldman, CA | 1 |
| Anselmo, LC | 1 |
| Lopes, KW | 1 |
| Drumond Neto, C | 1 |
| Reis, NB | 1 |
| Li, C | 1 |
| Wang, F | 1 |
| Wang, LJ | 1 |
| Li, CK | 1 |
| Golf, S | 1 |
| Jahnsen, T | 1 |
| Simonsen, S | 1 |
| Attramadal, A | 1 |
| Hansson, V | 1 |
| Neumann, J | 1 |
| von Meyerinck, L | 1 |
| Döring, V | 1 |
| Kalmar, P | 1 |
| Staley, NA | 1 |
| Einzig, S | 1 |
| Noren, GR | 1 |
| Surdy, JE | 1 |
| Elsperger, J | 1 |
| Camacho, SA | 1 |
| Wikman-Coffelt, J | 1 |
| Wu, ST | 1 |
| Watters, TA | 1 |
| Botvinick, EH | 1 |
| Sievers, R | 1 |
| James, TL | 1 |
| Jasmin, G | 1 |
| Parmley, WW | 1 |
| Ito, I | 1 |
| Krzyś, T | 1 |
| Kalawski, R | 1 |
| Flaczyński, K | 1 |
| Lenartowicz, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Clinical Trial, Investigating the Effect of a Home-based Moderate Intensity Training Program on Oxidative Capacity and Hemodynamics in Patients With Truncating Genetic Variants in TTN.[NCT05180188] | 14 participants (Actual) | Interventional | 2022-02-14 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for isoproterenol and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
A novel scheme of dystrophin disruption for the progression of advanced heart failure.
Topics: Animals; Calcium-Binding Proteins; Calpain; Cardiomyopathy, Dilated; Cell Membrane Permeability; Cri | 2005 |
1 trial available for isoproterenol and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Using isoproterenol stress echocardiography to predict the response to carvedilol in patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Contraind | 2001 |
88 other studies available for isoproterenol and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Haplo-insufficiency of Bcl2-associated athanogene 3 in mice results in progressive left ventricular dysfunction, β-adrenergic insensitivity, and increased apoptosis.
Topics: Adaptor Proteins, Signal Transducing; Adrenergic Agents; Animals; Apoptosis; Apoptosis Regulatory Pr | 2018 |
Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Cell Differentiation; Connectin; Excitation Contraction Coupli | 2018 |
Functional Annotation of TNNT2 Variants of Uncertain Significance With Genome-Edited Cardiomyocytes.
Topics: Action Potentials; Cardiomyopathy, Dilated; CRISPR-Cas Systems; Gene Editing; Humans; Induced Plurip | 2018 |
SLMAP-3 is downregulated in human dilated ventricles and its overexpression promotes cardiomyocyte response to adrenergic stimuli by increasing intracellular calcium.
Topics: Animals; Calcium; Cardiomyopathy, Dilated; Cell Line; Down-Regulation; Gene Knockdown Techniques; He | 2019 |
MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.
Topics: Amino Acid Sequence; Animals; Calcineurin; Cardiomegaly; Cardiomyopathy, Dilated; Disease Models, An | 2013 |
Telomere length and adrenergic-induced left ventricular dilatation and systolic chamber dysfunction in rats.
Topics: Adrenergic beta-Agonists; Animals; Cardiomyopathy, Dilated; Heart Ventricles; Isoproterenol; Male; R | 2013 |
Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence.
Topics: Aging; Animals; Cardiomyopathy, Dilated; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; | 2015 |
A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia.
Topics: Aged; Animals; Arrhythmias, Cardiac; Calcium; Calcium-Binding Proteins; Cardiomyopathy, Dilated; Cel | 2015 |
Interplay between the E2F pathway and β-adrenergic signaling in the pathological hypertrophic response of myocardium.
Topics: Animals; Calcium-Binding Proteins; Cardiomegaly; Cardiomyopathy, Dilated; Cell Survival; Cyclic AMP- | 2015 |
Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy.
Topics: Adrenergic beta-Agonists; Cardiomyopathy, Dilated; Cell Differentiation; Cells, Cultured; Cyclic Nuc | 2015 |
HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy.
Topics: Adrenergic beta-Agonists; Cardiomyopathy, Dilated; Cells, Cultured; Connectin; Heart Rate; Humans; I | 2015 |
BAG3 regulates contractility and Ca(2+) homeostasis in adult mouse ventricular myocytes.
Topics: Action Potentials; Adaptor Proteins, Signal Transducing; Animals; Apoptosis Regulatory Proteins; Arr | 2016 |
Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.
Topics: A Kinase Anchor Proteins; Animals; Calcineurin; Calcium Signaling; Calcium-Binding Proteins; Cardiom | 2017 |
Altered myocyte contractility and calcium homeostasis in alpha-myosin heavy chain point mutations linked to familial dilated cardiomyopathy.
Topics: Animals; Calcium; Cardiomyopathy, Dilated; Homeostasis; Humans; Hypertrophy; Isoproterenol; Kinetics | 2017 |
Human mutation in the anti-apoptotic heat shock protein 20 abrogates its cardioprotective effects.
Topics: Amino Acid Substitution; Animals; Apoptosis; Cardiomyopathy, Dilated; Cardiotonic Agents; Cells, Cul | 2008 |
Dilated cardiomyopathy in transgenic mice expressing HIV Tat.
Topics: Adrenergic beta-Agonists; Age Factors; Animals; Blood Pressure; Bradycardia; Cardiomyopathy, Dilated | 2009 |
Defects in myoglobin oxygenation in K(ATP)-deficient mouse hearts under normal and stress conditions characterized by near infrared spectroscopy and imaging.
Topics: 2,4-Dinitrophenol; Acute Disease; Animals; Cardiomyopathy, Dilated; Cardiotonic Agents; Female; In V | 2011 |
Prolonged mechanical unloading preserves myocardial contractility but impairs relaxation in rat heart of dilated cardiomyopathy accompanied by myocardial stiffness and apoptosis.
Topics: Adrenergic beta-Agonists; Animals; Apoptosis; Cardiomyopathy, Dilated; Collagen Type I; Diastole; Di | 2010 |
Impact of aldosterone receptor blockade on the deleterious cardiac effects of adrenergic activation in hypertensive rats.
Topics: Adrenergic beta-Agonists; Animals; Apoptosis; Blood Pressure; Cardiomyopathy, Dilated; Hypertension; | 2010 |
Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Antibody Speci | 2011 |
Ahnak1 is a tuneable modulator of cardiac Ca(v)1.2 calcium channel activity.
Topics: Adrenergic beta-Agonists; Amino Acid Motifs; Animals; Binding Sites; Calcium; Calcium Channels, L-Ty | 2011 |
Reverse chamber remodelling following adrenergic-induced advanced cardiac dilatation and pump dysfunction.
Topics: Adrenergic beta-Agonists; Animals; Apoptosis; Cardiomyopathy, Dilated; Isoproterenol; Male; Myocytes | 2012 |
Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I.
Topics: Adrenergic beta-Agonists; Analysis of Variance; Angiotensin II; Animals; Aorta; Blood Pressure; Calc | 2013 |
Impact of human autoantibodies on β1-adrenergic receptor conformation, activity, and internalization.
Topics: Adrenergic beta-Agonists; Autoantibodies; Cardiomyopathy, Dilated; Case-Control Studies; Cells, Cult | 2013 |
β1-Adrenoceptor autoantibodies from DCM patients enhance the proliferation of T lymphocytes through the β1-AR/cAMP/PKA and p38 MAPK pathways.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Agonists; Aged; Animals; Autoantibodies; Car | 2012 |
Cardiac troponin T variants produced by aberrant splicing of multiple exons in animals with high instances of dilated cardiomyopathy.
Topics: Alternative Splicing; Amino Acid Sequence; Animals; Base Sequence; Cardiomyopathy, Dilated; Cats; Cl | 2002 |
Exaggerated cardiovascular effects of cocaine in conscious dogs with pacing-induced dilated cardiomyopathy.
Topics: Adrenergic beta-Agonists; Animals; Baroreflex; Biomarkers; Cardiac Pacing, Artificial; Cardiomyopath | 2002 |
Ser16-, but not Thr17-phosphorylation of phospholamban influences frequency-dependent force generation in human myocardium.
Topics: Adrenergic beta-Agonists; Adult; Calcium-Binding Proteins; Calcium-Transporting ATPases; Cardiac Out | 2003 |
Plasma membrane-associated nucleoside diphosphate kinase (nm23) in the heart is regulated by beta-adrenergic signaling.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Animals; Card | 2003 |
Sera from patients with idiopathic dilated cardiomyopathy decrease ICa in cardiomyocytes isolated from rabbits.
Topics: Action Potentials; Adrenergic beta-Agonists; Adult; Aged; Animals; Autoantibodies; Calcium Channels, | 2004 |
Electromechanical properties of Purkinje fiber strands isolated from human ventricular endocardium.
Topics: Adult; Cardiomyopathy, Dilated; Cardiotonic Agents; Endocardium; Female; Humans; Isoproterenol; Male | 2004 |
[Causes and prognosis of syncope in patients with primary dilated cardiomyopathy].
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Cardiotonic Agents; E | 2004 |
Coronary blood flow responses are impaired independent of NO and endothelial function in conscious dogs with dilated cardiomyopathy.
Topics: Acetylcholine; Adenosine; Adrenergic beta-Agonists; Animals; Calcium Channel Blockers; Cardiomyopath | 2005 |
Effects of immunoglobulin G from patients with dilated cardiomyopathy on rat cardiomyocytes.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Autoantibodies; Calcium; Calcium Channels, L-T | 2005 |
The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy.
Topics: Adrenergic Antagonists; Adrenergic beta-Agonists; Animals; Carbazoles; Cardiomyopathy, Dilated; Carv | 2006 |
Anti-beta1-adrenergic receptor autoantibodies are potent stimulators of the ERK1/2 pathway in cardiac cells.
Topics: Adrenergic beta-Agonists; Animals; Autoantibodies; Cardiomyopathy, Dilated; Cell Line; Cells, Cultur | 2007 |
Clinical electrophysiology of ventricular tachycardia.
Topics: Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Coronary Disease; Elect | 1983 |
The diversity of left ventricular responses to isoproterenol and dibutyryl cyclic AMP infusion in patients with dilated cardiomyopathy.
Topics: Adult; Aged; Bucladesine; Cardiomyopathy, Dilated; Female; Heart Ventricles; Hemodynamics; Humans; I | 1995 |
Effect of isoproterenol on serum potassium and magnesium.
Topics: Adult; Aged; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Diag | 1993 |
Bovine hereditary cardiomyopathy: an animal model of human dilated cardiomyopathy.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Animals; Cardiomyopathies; Cardiomyopathy, Dilated; Cate | 1995 |
Response to isoproterenol as a prognostic indicator of evolution from hypertrophic cardiomyopathy to a phase resembling dilated cardiomyopathy.
Topics: Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Disease Progression; Echocardiography; Female | 1995 |
The novel effects of 3,5,3'-triiodo-L-thyronine on myocyte contractile function and beta-adrenergic responsiveness in dilated cardiomyopathy.
Topics: Animals; Cardiomyopathy, Dilated; Cardiotonic Agents; Cells, Cultured; Isoproterenol; Myocardial Con | 1994 |
Pathophysiological and biochemical characterisation of an avian model of dilated cardiomyopathy: comparison to findings in human dilated cardiomyopathy.
Topics: Adenosine Triphosphatases; Animals; Calcium; Cardiomyopathy, Dilated; Culture Techniques; Disease Mo | 1993 |
Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.
Topics: Adult; Base Sequence; beta-Adrenergic Receptor Kinases; Binding, Competitive; Calcium; Cardiac Outpu | 1993 |
beta-Adrenergic modulation of the inwardly rectifying potassium channel in isolated human ventricular myocytes. Alteration in channel response to beta-adrenergic stimulation in failing human hearts.
Topics: Adrenergic beta-Agonists; Adult; Alkaline Phosphatase; Analysis of Variance; Barium; Bucladesine; Ca | 1995 |
Right and left ventricular geometry and myocyte contractile processes with dilated cardiomyopathy: myocyte growth and beta-adrenergic responsiveness.
Topics: Adrenergic beta-Agonists; Animals; Cardiomyopathy, Dilated; Cell Size; Cells, Cultured; Heart Ventri | 1996 |
Pathophysiologic significance of left ventricular hypertrophy in dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Catecholamines; Female; Humans; Hypertroph | 1996 |
Shortening versus isometric contractions in isolated human failing and non-failing left ventricular myocardium: dependency of external work and force on muscle length, heart rate and inotropic stimulation.
Topics: Adolescent; Adult; Aged; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Heart Rate; Humans; I | 1998 |
Agonistic anti-beta1-adrenergic receptor autoantibodies from cardiomyopathy patients reduce the beta1-adrenergic receptor expression in neonatal rat cardiomyocytes.
Topics: Adrenergic beta-Agonists; Animals; Animals, Newborn; Antibodies; Autoantibodies; Blotting, Western; | 1998 |
Beta-adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; A | 1998 |
Alterations of cross-bridge kinetics in human atrial and ventricular myocardium.
Topics: Actomyosin; Adrenergic beta-Agonists; Barium Compounds; Body Temperature; Cardiomyopathy, Dilated; C | 1998 |
Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Cardiomyopathy, Dilated; Cyclic AMP; Echocardi | 1999 |
Acute dilated cardiomyopathy and central nervous system toxicity following propranolol intoxication.
Topics: Acute Disease; Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Antidotes; Cardiom | 1999 |
Treatment of severe chronic digoxin toxicosis in a dog with cardiac disease, using ovine digoxin-specific immunoglobulin G Fab fragments.
Topics: Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Blood Cell Count; Blood Chemical Analysis; | 1999 |
Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene.
Topics: Adrenergic beta-Agonists; Animals; beta-Adrenergic Receptor Kinases; Cardiomegaly; Cardiomyopathy, D | 2001 |
Impaired ability to secrete atrial natriuretic peptide in response to isoproterenol infusion in patients with dilated cardiomyopathy.
Topics: Adrenergic beta-Agonists; Aged; Atrial Natriuretic Factor; Cardiomyopathy, Dilated; Echocardiography | 2001 |
Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium.
Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adult; Biopsy; Blotting, Western; Car | 2001 |
Catecholamine stimulation is associated with impaired myocardial O(2) utilization in heart failure.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Varian | 2002 |
Heart function challenged with beta-receptor agonism or antagonism in a heart failure model.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Blood Pressure; Ca | 2001 |
Involvement of inducible nitric oxide synthase in cardiac dysfunction with tumor necrosis factor-alpha.
Topics: Adrenergic beta-Agonists; Amidines; Animals; Blotting, Northern; Cardiomyopathy, Dilated; Echocardio | 2002 |
Type 1 phosphatase, a negative regulator of cardiac function.
Topics: Adrenergic beta-Agonists; Animals; Cardiomyopathy, Dilated; Carrier Proteins; Cells, Cultured; Endor | 2002 |
Inotropic and lusitropic dysfunction in myocardium from patients with dilated cardiomyopathy.
Topics: Calcium; Cardiomyopathy, Dilated; Heart; Humans; In Vitro Techniques; Isometric Contraction; Isoprot | 1992 |
Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms.
Topics: Adenylyl Cyclases; Adult; Cardiomyopathy, Dilated; Catecholamines; Female; Heart; Heart Failure; Hum | 1992 |
Assessment of immune modulation of beta-adrenergic pathways in human dilated cardiomyopathy: influence of methodologic factors.
Topics: Adenylyl Cyclases; Adult; Autoantibodies; Cardiomyopathy, Dilated; Enzyme-Linked Immunosorbent Assay | 1992 |
Immune-mediated modulation of sarcoplasmic reticulum function in human dilated cardiomyopathy.
Topics: Adult; Animals; Autoantibodies; Binding Sites, Antibody; Biological Transport; Calcium; Cardiomyopat | 1992 |
Effects of chronic tachycardia-induced cardiomyopathy on the beta-adrenergic receptor system.
Topics: Animals; Cardiomyopathy, Dilated; Chronic Disease; Isoproterenol; Myocardial Contraction; Myocardium | 1992 |
Quantification of Gi alpha-proteins in the failing and nonfailing human myocardium.
Topics: Amino Acid Sequence; Antibodies; Cardiomyopathy, Dilated; Coronary Disease; GTP-Binding Proteins; He | 1992 |
Regulation and possible functional implications of G-protein mRNA expression in nonfailing and failing ventricular myocardium.
Topics: Adult; Animals; Carbachol; Cardiomyopathy, Dilated; Coronary Disease; Female; Gene Expression Regula | 1992 |
Force-frequency relationship and inotropic stimulation in the nonfailing and failing human myocardium: implications for the medical treatment of heart failure.
Topics: Adult; Cardiomyopathy, Dilated; Female; Heart Rate; Humans; Isoproterenol; Male; Middle Aged; Myocar | 1992 |
Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors.
Topics: Adult; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Catecholamines; Enoximone; Female; Hear | 1991 |
Different beta-adrenoceptor-effector coupling in human ventricular and atrial myocardium.
Topics: Adult; Cardiomyopathy, Dilated; Female; Heart Atria; Heart Failure; Heart Ventricles; Humans; Isopro | 1991 |
Evidence for a sustained effectiveness of sodium-channel activators in failing human myocardium.
Topics: Adult; Azetidines; Cardiomyopathy, Dilated; Cardiotonic Agents; Cell Membrane; Dose-Response Relatio | 1991 |
Characteristics of calcium-current in isolated human ventricular myocytes from patients with terminal heart failure.
Topics: Action Potentials; Calcium Channels; Cardiomyopathy, Dilated; Cell Separation; Coronary Disease; Hea | 1991 |
Neurohumoral regulation of excitation-contraction coupling in ventricular myocytes from cardiomyopathic hamsters.
Topics: Animals; Carbachol; Cardiomyopathy, Dilated; Cell Membrane; Cricetinae; Electrophysiology; Heart; Is | 1991 |
Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure.
Topics: Adult; Animals; Atropine; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Dogs; Electrocardiogr | 1991 |
Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; D | 1991 |
Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy.
Topics: Adenosine Diphosphate Ribose; Adenylate Cyclase Toxin; Adenylyl Cyclases; Adult; Carbachol; Cardiomy | 1990 |
[Value of the isoprenaline test in arrhythmogenic heart diseases].
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Drug Evaluation; Elec | 1989 |
Beta-adrenergic receptor number and adenylate cyclase function in denervated transplanted and cardiomyopathic human hearts.
Topics: Adenylyl Cyclases; Adolescent; Adult; Cardiomyopathy, Dilated; Endocardium; Heart; Heart Transplanta | 1989 |
Drug- and disease-induced changes of human cardiac beta 1- and beta 2-adrenoceptors.
Topics: Adolescent; Adult; Cardiomyopathy, Dilated; Child; Child, Preschool; Coronary Disease; Heart Failure | 1989 |
[Cardiac performance and hemodynamic response under the effect of isoproterenol and D-isosorbitol in patients with dilated cardiomyopathy].
Topics: Adolescent; Adult; Blood Pressure; Cardiomyopathy, Dilated; Female; Heart Ventricles; Hemodynamics; | 1989 |
Increased sarcolemmal membrane permeability of cardiac muscle cells in rats fed grains cultivated in a Keshan disease endemic area: a study with horseradish peroxidase as a tracer.
Topics: Animals; Cardiomyopathy, Dilated; Cell Membrane Permeability; Diet; Edible Grain; Horseradish Peroxi | 1989 |
Catecholamine-responsive adenylate cyclase activity in human endomyocardial biopsies. Individual sensitivity to isoproterenol stimulation and propranolol inhibition.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Cardiomyopathy, Dil | 1985 |
Increase in myocardial Gi-proteins in heart failure.
Topics: Cardiomyopathy, Dilated; GTP-Binding Proteins; Heart Failure; Humans; Isometric Contraction; Isoprot | 1988 |
Beta-adrenergic function in a congestive cardiomyopathy model.
Topics: Adenylyl Cyclases; Animals; Cardiomyopathy, Dilated; Echocardiography; Hemodynamics; Isoproterenol; | 1987 |
Improvement in myocardial performance without a decrease in high-energy phosphate metabolites after isoproterenol in Syrian cardiomyopathic hamsters.
Topics: Adenosine Triphosphate; Animals; Calcium; Cardiomyopathy, Dilated; Cricetinae; Hydrogen-Ion Concentr | 1988 |
The prognostic significance of left ventricular response to isoproterenol infusion in patients with dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Echocardiography; Female; Follow-Up Studies; Heart Function Te | 1987 |
[Combined use of isoprenaline and hydralazine in the treatment of chronic circulatory insufficiency].
Topics: Adult; Cardiomyopathy, Dilated; Chronic Disease; Drug Therapy, Combination; Female; Heart Failure; H | 1985 |